Hong Kong · Delayed Price · Currency is HKD BioDlink International Company Company Description
BioDlink International Company Limited, an investment holding company, engages in the research, development, manufacturing, and marketing of anti-tumor drugs in Mainland China and internationally.
The company offers Pusintin, a bevacizumab injection to treat metastatic colorectal cancer; advanced, metastatic or recurrent non-small cell lung cancer; recurrent glioblastoma multiforme; epithelial ovarian cancer; fallopian tube cancer or primary peritoneal cancer; and cervical cancer.
It also provides Tazian, a temozolomide capsule for the treatment of glioblastoma and anaplastic astrocytoma.
In addition, the company develops TAB014 a bevacizumab ophthalmic drug for the treatment of wet age-related macular degeneration (wAMD).
Further, it engages in contract development and manufacturing organization (CDMO)/contract manufacture organization (CMO) business; license-out of self-developed biological drugs; and business development, investing, and marketing promotion activities.
The company was formerly known as TOT BIOPHARM International Company Limited and changed its name to BioDlink International Company Limited in July 2025.
BioDlink International Company Limited was incorporated in 2009 and is headquartered in Suzhou, China.
BioDlink International Company Limited operates as a subsidiary of WuXi XDC Cayman Inc.
| Country | Hong Kong |
| Founded | 2009 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 613 |
| CEO | Jun Liu |
Contact Details
Address: No. 120 Changyang Street Suzhou, 215024 China | |
| Phone | 86 512 6296 5186 |
| Website | biodlink.com |
Stock Details
| Ticker Symbol | 1875 |
| Exchange | Hong Kong Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | HK0000545266 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Jincai Li Ph.D. | Executive Chairman of the Board |
| Ben Xiao | Group Vice President of Finance and Investor Relations |
| Dr. Jian Bo Zhang | Chief Operating Officer |
| Li Yin | Chief Technology Officer |
| Wing Yat Lui | Joint Company Secretary |
| Yifan Chen | Joint Company Secretary |